GLP-1s have rapidly increased in popularity, Due to their seemingly remarkable ability to facilitate weight loss. These findings have led to increased interest in understanding whether GLP-1s might be useful for changing other behaviors, such as as substance use. In this episode, Dr. Joseph Schacht discusses the science behind GLP-1 medications and their potential as treatments for substance use disorders, including recent research, mechanisms, and future directions. Dr. Joseph Schacht is an Associate Professor and Co-Director of the Division of Addiction Science, Prevention, and Treatment in the Department of Psychiatry at the University of Colorado Anschutz. Learn more about his work here.